Exercise Helps With Body Image, Depression In Pregnancy Exercise can help expectant moms in mind as well as body. A new study suggests that women who stay active and are more positive about their changing shapes might protect themselves from depression both during and after pregnancy. "Our study supports the psychological benefits of exercise to improve body image and lessen depressive symptoms," said lead study author Danielle Symons Downs, Ph.D.
Source: www.medicalnewstoday.comNatural Childbirth Makes Mothers More Responsive To Own Baby-Cry A new study has found that mothers who delivered vaginally compared to caesarean section delivery (CSD) were significantly more responsive to the cry of their own baby, identified through MRI brain scans two to four weeks after delivery.
Source: www.medicalnewstoday.comSociety Of Obstetricians And Gynaecologists Of Canada Recommends That Parliament Reject Bill C-484 The Society of Obstetricians and Gynaecologists of Canada (SOGC) is profoundly troubled by private member's Bill C-484, entitled the Unborn Victims of Crime Act, and opposes its passage into law. This Bill can only be interpreted as giving the foetus in utero legal status at conception.
Source: www.medicalnewstoday.comPhase III Clinical Studies Of Aclidinium Bromide Show Statistical Significance Vs. Placebo In Patients With Chronic Obstructive Pulmonary Disease Forest Laboratories, Inc. (NYSE: FRX) and Laboratorios Almirall, S.A. announced results from two global Phase III studies of aclidinium bromide, a novel long-acting inhaled anticholinergic for the treatment of patients with chronic obstructive pulmonary disease (COPD).
Source: www.medicalnewstoday.comFast Track Drugs Reach Market Sooner, According To Tufts Center For The Study Of Drug Development New
drugs that receive fast track designation by the U.S. Food and Drug Administration (FDA) experience shorter clinical and approval times compared to
drugs without the designation, according to a recently completed study of the first decade of the fast track program conducted by the Tufts Center for the Study of Drug Development. Total average clinical and approval time for fast track
drugs was 5% faster than for all
drugs -- 73.1 vs. 77.
Source: www.medicalnewstoday.comFDA Approvals For Dexamethasone Sodium Phosphate Injection USP, 4 Mg (Base)/mL And Dexamethasone Sodium Phosphate Injection USP, 10 Mg (Base)/mL Akorn-Strides, LLC announced the approval of two ANDAs for Dexamethasone Sodium Phosphate Injection USP, 4 mg (base)/mL in 1mL, 5 mL, and 30 mL vials, and Dexamethasone Sodium Phosphate Injection USP, 10 mg (base)/mL in 10 mL vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE: STAR)(BSE: 532531).
Source: www.medicalnewstoday.com
# posted by Network @ 12:00 PM
